Genkyotex, the leading developer of NOX enzyme inhibitors, has announced that a group of collaborators have discovered a link between the enzyme NOX4 and development of osteoporosis. These results, published online in the Journal of Clinical Investigation, indicate that inhibitors of NOX4, such as GKT137831 developed by Genkyotex could lead to a novel way of treating patients with osteoporosis...
No comments:
Post a Comment